Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-13-145468
Filing Date
2013-04-08
Accepted
2013-04-08 12:17:24
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d516187dsc13ga.htm SC 13G/A 35291
  Complete submission text file 0001193125-13-145468.txt   37211
Mailing Address 227 W MONROE ST STE 3000 CHICAGO IL 60606
Business Address 227 W MONROE STREET SUITE 3000 CHICAGO IL 60606 312-634-9200
COLUMBIA WANGER ASSET MANAGEMENT LLC (Filed by) CIK: 0000908733 (see all company filings)

EIN.: 043519872 | Fiscal Year End: 1231
Type: SC 13G/A
SIC: 0000

Mailing Address 3530 TORINGDON WAY SUITE 200 CHARLOTTE NC 28277
Business Address 3530 TORINGDON WAY SUITE 200 CHARLOTTE NC 28277 704-341-1516
Chelsea Therapeutics International, Ltd. (Subject) CIK: 0001333763 (see all company filings)

EIN.: 203174202 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-81457 | Film No.: 13747820
SIC: 2836 Biological Products, (No Diagnostic Substances)